We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Two Proteins Involved in Alzheimer's Disease

By Biotechdaily staff writers
Posted on 22 Jul 2002
Two recently discovered proteins, aph-1 and pen-2, have been shown to play a role in the production of beta-amyloid, the main constituent of senile plaques associated with Alzheimer's disease. More...
The two proteins are required for the activity of a third protein, presenilin, a key component of gamma-secretase, one of the two proteases responsible for the production of beta-amyloid. A report on the discovery was published in the July 2002 issue of Developmental Cell.

The study resulted from a joint project conducted by researchers from Exelixis, Inc. (San Francisco, CA, USA) and Pharmacia Corp. (Peapack, NJ, USA).

The research effort relied in part on Exelixis' expertise in using comparative genetics, functional genomics, and model systems to carry out a series of genetic screens in worms (C elegans) to elucidate the biological pathways involved in beta-amyloid production. These screens were based on the Notch signaling pathway, since gamma-secretase is known to play a dual role in cleavage both of Notch receptors and of the beta-amyloid precursor protein, betaAPP. Through systematic mutation and observation of the resultant phenotypic changes, the essential, conserved role of aph-1 and pen-2 in gamma-secretase activity was identified. Confirmation studies were performed in Drosophila and by demonstrating that the human orthologs of aph-1 and pen-2 were functional in the C elegans signaling context.

"The discovery of these two critically important proteins demonstrates the specificity of Exelixis' proprietary model system platform to discover novel gene targets that could have significant preventive and therapeutic potential against debilitating neurological diseases,” said Dr. George A. Scangos, president and CEO of Exelixis.


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
HPV Test
Allplex HPV28 Detection
New
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.